Articles Tagged With: efficacy
-
Sotrovimab Injection
In vitro neutralization data, artificial intelligence modeling, and anecdotal reports suggest sotrovimab is effective against the omicron variant while the efficacy of other monoclonal antibodies appears to wane.
-
In Addition to Vaccination, Can More Be Done to Prevent Severe COVID-19?
Using data for more than 1.2 million Americans who completed primary vaccination against COVID-19, severe disease outcomes were rare; however, vaccinated persons aged ≥ 65 years with immunosuppression or other underlying conditions were found to be at higher risk.
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
Adjuvanted Zoster Vaccine: Persistent Protection
The adjuvanted recombinant zoster vaccine efficacy is high and persistent, with apparent plateauing at > 84% four to six years after vaccination.
-
Two Similar Studies, Two Different Conclusions: What Is the Best Way to Treat Sepsis?
The authors of two recent studies of the performance of the Epic Sepsis Model (ESM), a commonly used early warning tool for sepsis, reached different conclusions: One research group found ESM fails to predict many sepsis cases beyond what clinicians detect on their own, but another research group reported the tool enhances care.
-
Jury Still Out on Convalescent Plasma
One year after the FDA issued an emergency use authorization, investigators are struggling to draw firm conclusions about the efficacy of this solution against COVID-19.
-
U.S. Slips in Blood Pressure Management
After years of improvement in this area, investigators recently observed troubling decline in rate control. -
The Levonorgestrel IUD Is Similarly Effective as the Copper IUD for Emergency Contraception
In this randomized, noninferiority trial among patients seeking emergency contraception after at least one episode of unprotected intercourse within five days of presentation, the levonorgestrel 52-mg intrauterine device (IUD) was noninferior to the copper T30A IUD at preventing pregnancy one month after IUD insertion. Adverse events between the two groups were similar.
-
AstraZeneca Reports 79% Efficacy for U.S. COVID-19 Vaccine Candidate
But NIH raises questions the about data.
-
Paclitaxel-Eluting Devices: Is It Time to Stop Worrying?
Paclitaxel-eluting devices vs. bare metal stents in peripheral arterial disease showed no significant difference in all-cause mortality, contradicting the results of a controversial meta-analysis.